Intra-Cellular Therapies
ITCI
#1263
Rank
S$18.73 B
Marketcap
$175.85
Share price
0.00%
Change (1 day)
95.19%
Change (1 year)

Revenue for Intra-Cellular Therapies (ITCI)

Revenue in 2024 (TTM): S$0.90 Billion

According to Intra-Cellular Therapies's latest financial reports the company's current revenue (TTM ) is S$0.90 Billion. an increase over the revenue in the year 2023 that were of S$0.61 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Intra-Cellular Therapies from 2014 to 2024

Annual revenue

Year Revenue Change
2024 S$0.92 B51.54%
2023 S$0.61 B82.76%
2022 S$0.33 B202.35%
2021 S$0.11 B270.59%
2020 S$29.8 M36375.58%
2019 S$0.08 M
2018 N/A
2017 N/A
2016 N/A-100%
2015 S$0.04 M-94.01%
2014 S$0.72 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
S$13.68 M-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.17 B-81.23%๐Ÿ‡บ๐Ÿ‡ธ USA